Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the three cell therapy programs they currently have in clinical trials: OpRegen – a cell replacement therapy for the treatment of advanced dry age-related macular degeneration (dry AMD), OPC1 – a cell replacement therapy for the treatment of acute spinal cord injuries, and […]

Dr. Maxime Descoteaux, Co-founder and CSO of Imeka, “the only company to combine diffusion and AI to map white matter integrity” discusses the use of white matter free water biomarker in Alzheimer’s disease and why scientists should change their focus from grey matter to white matter when it comes to evaluating Alzheimer’s disease.  He also […]

Peter H. Diamandis, PhD, calls himself a “data-driven optimist,” which is a necessary quality for an entrepreneur who relishes tackling grand challenges. His XPRIZE Foundation has created $10-million incentive competitions focused on the life sciences and other areas, while his venture capital fund, BOLD Capital Partners, has invested $250 million in innovative or “exponential” technologies. […]